Cargando…
Intranasal Immunization with a Recombinant Avian Paramyxovirus Serotypes 2 Vector-Based Vaccine Induces Protection against H9N2 Avian Influenza in Chicken
Commercial inactivated vaccines against H9N2 avian influenza (AI) have been developed in China since 1990s and show excellent immunogenicity with strong HI antibodies. However, currently approved vaccines cannot meet the clinical demand for a live-vectored vaccine. Newcastle disease virus (NDV) vect...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9144924/ https://www.ncbi.nlm.nih.gov/pubmed/35632659 http://dx.doi.org/10.3390/v14050918 |
_version_ | 1784716166963396608 |
---|---|
author | Yang, Wenhao Dai, Jing Liu, Jingjing Guo, Mengjiao Liu, Xiaowen Hu, Shunlin Gu, Min Hu, Jiao Hu, Zenglei Gao, Ruyi Liu, Kaituo Chen, Yu Liu, Xiufan Wang, Xiaoquan |
author_facet | Yang, Wenhao Dai, Jing Liu, Jingjing Guo, Mengjiao Liu, Xiaowen Hu, Shunlin Gu, Min Hu, Jiao Hu, Zenglei Gao, Ruyi Liu, Kaituo Chen, Yu Liu, Xiufan Wang, Xiaoquan |
author_sort | Yang, Wenhao |
collection | PubMed |
description | Commercial inactivated vaccines against H9N2 avian influenza (AI) have been developed in China since 1990s and show excellent immunogenicity with strong HI antibodies. However, currently approved vaccines cannot meet the clinical demand for a live-vectored vaccine. Newcastle disease virus (NDV) vectored vaccines have shown effective protection in chickens against H9N2 virus. However, preexisting NDV antibodies may affect protective efficacy of the vaccine in the field. Here, we explored avian paramyxovirus serotype 2 (APMV-2) as a vector for developing an H9N2 vaccine via intranasal delivery. APMV-2 belongs to the same genus as NDV, distantly related to NDV in the phylogenetic tree, based on the sequences of Fusion (F) and hemagglutinin-neuraminidase (HN) gene, and has low cross-reactivity with anti-NDV antisera. We incorporated hemagglutinin (HA) of H9N2 into the junction of P and M gene in the APMV-2 genome by being flanked with the gene start, gene end, and UTR of each gene of APMV-2-T4 to generate seven recombinant APMV-2 viruses rAPMV-2/HAs, rAPMV-2-NPUTR-HA, rAPMV-2-PUTR-HA, rAPMV-2-FUTR-HA, rAPMV-2-HNUTR-HA, rAPMV-2-LUTR-HA, and rAPMV-2-MUTR-HA, expressing HA. The rAPMV-2/HAs displayed similar pathogenicity compared with the parental APMV-2-T4 virus and expressed HA protein in infected CEF cells. The NP-UTR facilitated the expression and secretion of HA protein in cells infected with rAPMV-2-NPUTR-HA. Animal studies demonstrated that immunization with rAPMV-2-NPUTR-HA elicited effective H9N2-specific antibody (6.14 ± 1.2 log2) responses and conferred complete immune protection to prevent viral shedding in the oropharyngeal and cloacal swabs from chickens challenged with H9N2 virus. This study suggests that our recombinant APMV-2 virus is safe and immunogenic and can be a useful tool in the combat of H9N2 outbreaks in chicken. |
format | Online Article Text |
id | pubmed-9144924 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-91449242022-05-29 Intranasal Immunization with a Recombinant Avian Paramyxovirus Serotypes 2 Vector-Based Vaccine Induces Protection against H9N2 Avian Influenza in Chicken Yang, Wenhao Dai, Jing Liu, Jingjing Guo, Mengjiao Liu, Xiaowen Hu, Shunlin Gu, Min Hu, Jiao Hu, Zenglei Gao, Ruyi Liu, Kaituo Chen, Yu Liu, Xiufan Wang, Xiaoquan Viruses Article Commercial inactivated vaccines against H9N2 avian influenza (AI) have been developed in China since 1990s and show excellent immunogenicity with strong HI antibodies. However, currently approved vaccines cannot meet the clinical demand for a live-vectored vaccine. Newcastle disease virus (NDV) vectored vaccines have shown effective protection in chickens against H9N2 virus. However, preexisting NDV antibodies may affect protective efficacy of the vaccine in the field. Here, we explored avian paramyxovirus serotype 2 (APMV-2) as a vector for developing an H9N2 vaccine via intranasal delivery. APMV-2 belongs to the same genus as NDV, distantly related to NDV in the phylogenetic tree, based on the sequences of Fusion (F) and hemagglutinin-neuraminidase (HN) gene, and has low cross-reactivity with anti-NDV antisera. We incorporated hemagglutinin (HA) of H9N2 into the junction of P and M gene in the APMV-2 genome by being flanked with the gene start, gene end, and UTR of each gene of APMV-2-T4 to generate seven recombinant APMV-2 viruses rAPMV-2/HAs, rAPMV-2-NPUTR-HA, rAPMV-2-PUTR-HA, rAPMV-2-FUTR-HA, rAPMV-2-HNUTR-HA, rAPMV-2-LUTR-HA, and rAPMV-2-MUTR-HA, expressing HA. The rAPMV-2/HAs displayed similar pathogenicity compared with the parental APMV-2-T4 virus and expressed HA protein in infected CEF cells. The NP-UTR facilitated the expression and secretion of HA protein in cells infected with rAPMV-2-NPUTR-HA. Animal studies demonstrated that immunization with rAPMV-2-NPUTR-HA elicited effective H9N2-specific antibody (6.14 ± 1.2 log2) responses and conferred complete immune protection to prevent viral shedding in the oropharyngeal and cloacal swabs from chickens challenged with H9N2 virus. This study suggests that our recombinant APMV-2 virus is safe and immunogenic and can be a useful tool in the combat of H9N2 outbreaks in chicken. MDPI 2022-04-28 /pmc/articles/PMC9144924/ /pubmed/35632659 http://dx.doi.org/10.3390/v14050918 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Yang, Wenhao Dai, Jing Liu, Jingjing Guo, Mengjiao Liu, Xiaowen Hu, Shunlin Gu, Min Hu, Jiao Hu, Zenglei Gao, Ruyi Liu, Kaituo Chen, Yu Liu, Xiufan Wang, Xiaoquan Intranasal Immunization with a Recombinant Avian Paramyxovirus Serotypes 2 Vector-Based Vaccine Induces Protection against H9N2 Avian Influenza in Chicken |
title | Intranasal Immunization with a Recombinant Avian Paramyxovirus Serotypes 2 Vector-Based Vaccine Induces Protection against H9N2 Avian Influenza in Chicken |
title_full | Intranasal Immunization with a Recombinant Avian Paramyxovirus Serotypes 2 Vector-Based Vaccine Induces Protection against H9N2 Avian Influenza in Chicken |
title_fullStr | Intranasal Immunization with a Recombinant Avian Paramyxovirus Serotypes 2 Vector-Based Vaccine Induces Protection against H9N2 Avian Influenza in Chicken |
title_full_unstemmed | Intranasal Immunization with a Recombinant Avian Paramyxovirus Serotypes 2 Vector-Based Vaccine Induces Protection against H9N2 Avian Influenza in Chicken |
title_short | Intranasal Immunization with a Recombinant Avian Paramyxovirus Serotypes 2 Vector-Based Vaccine Induces Protection against H9N2 Avian Influenza in Chicken |
title_sort | intranasal immunization with a recombinant avian paramyxovirus serotypes 2 vector-based vaccine induces protection against h9n2 avian influenza in chicken |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9144924/ https://www.ncbi.nlm.nih.gov/pubmed/35632659 http://dx.doi.org/10.3390/v14050918 |
work_keys_str_mv | AT yangwenhao intranasalimmunizationwitharecombinantavianparamyxovirusserotypes2vectorbasedvaccineinducesprotectionagainsth9n2avianinfluenzainchicken AT daijing intranasalimmunizationwitharecombinantavianparamyxovirusserotypes2vectorbasedvaccineinducesprotectionagainsth9n2avianinfluenzainchicken AT liujingjing intranasalimmunizationwitharecombinantavianparamyxovirusserotypes2vectorbasedvaccineinducesprotectionagainsth9n2avianinfluenzainchicken AT guomengjiao intranasalimmunizationwitharecombinantavianparamyxovirusserotypes2vectorbasedvaccineinducesprotectionagainsth9n2avianinfluenzainchicken AT liuxiaowen intranasalimmunizationwitharecombinantavianparamyxovirusserotypes2vectorbasedvaccineinducesprotectionagainsth9n2avianinfluenzainchicken AT hushunlin intranasalimmunizationwitharecombinantavianparamyxovirusserotypes2vectorbasedvaccineinducesprotectionagainsth9n2avianinfluenzainchicken AT gumin intranasalimmunizationwitharecombinantavianparamyxovirusserotypes2vectorbasedvaccineinducesprotectionagainsth9n2avianinfluenzainchicken AT hujiao intranasalimmunizationwitharecombinantavianparamyxovirusserotypes2vectorbasedvaccineinducesprotectionagainsth9n2avianinfluenzainchicken AT huzenglei intranasalimmunizationwitharecombinantavianparamyxovirusserotypes2vectorbasedvaccineinducesprotectionagainsth9n2avianinfluenzainchicken AT gaoruyi intranasalimmunizationwitharecombinantavianparamyxovirusserotypes2vectorbasedvaccineinducesprotectionagainsth9n2avianinfluenzainchicken AT liukaituo intranasalimmunizationwitharecombinantavianparamyxovirusserotypes2vectorbasedvaccineinducesprotectionagainsth9n2avianinfluenzainchicken AT chenyu intranasalimmunizationwitharecombinantavianparamyxovirusserotypes2vectorbasedvaccineinducesprotectionagainsth9n2avianinfluenzainchicken AT liuxiufan intranasalimmunizationwitharecombinantavianparamyxovirusserotypes2vectorbasedvaccineinducesprotectionagainsth9n2avianinfluenzainchicken AT wangxiaoquan intranasalimmunizationwitharecombinantavianparamyxovirusserotypes2vectorbasedvaccineinducesprotectionagainsth9n2avianinfluenzainchicken |